US Antimicrobial Susceptibility Testing Market (2024-2029)
The US Antimicrobial Susceptibility Testing Market was valued at $1485.8 Million in 2024 and projected to reach to $1884.6 Million by 2029, representing a compound annual growth rate of CAGR 4.9%. The US antimicrobial susceptibility testing market is positioned for sustained growth through 2029, fueled by escalating antibiotic resistance concerns and heightened awareness among healthcare providers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Antimicrobial Susceptibility Testing Market Trends and Insights
- The US market is driven by rising antibiotic resistance, increased diagnostic demand in clinical laboratories, and regulatory emphasis on infection control.
- In the US, healthcare facilities are increasingly adopting automated and rapid testing platforms to improve patient outcomes and reduce hospital-acquired infections. The US antimicrobial susceptibility testing market benefits from advanced healthcare infrastructure, high laboratory automation adoption, and strong reimbursement frameworks.
- US hospitals and diagnostic centers are investing in next-generation testing technologies to combat multidrug-resistant pathogens.
- Between 2024 and 2029, the US market will see accelerated growth driven by technological innovation, expanded microbiology laboratory capacity, and heightened awareness of antimicrobial stewardship programs across US healthcare systems..
Key Market Statistics
- CAGR (2024-2029) CAGR 4.9%
- Market Size, 2024 ~USD 1485.8 Million
- Forecast, 2029 ~USD 1884.6 Million
- Country US
US Antimicrobial Susceptibility Testing Market Overview
Market Size & Growth :
The US antimicrobial susceptibility testing market reached $1,485.8 million in 2024 and is projected to expand to $1,884.6 million by 2029, representing a steady CAGR of 4.9% driven by clinical laboratory modernization.
Antibiotic Resistance Crisis :
Rising antibiotic resistance rates across US healthcare facilities are compelling hospitals and diagnostic labs to adopt advanced susceptibility testing methods to guide targeted antimicrobial therapy and reduce treatment failures.
Regulatory & Compliance Drivers :
US regulatory bodies including the CDC and CMS are enforcing stricter infection control protocols and antimicrobial stewardship programs, mandating comprehensive susceptibility testing in clinical laboratories nationwide.
Clinical Laboratory Expansion :
US healthcare facilities are significantly increasing investments in diagnostic infrastructure and automated susceptibility testing platforms to meet growing demand for rapid, accurate pathogen identification and resistance profiling.
US Antimicrobial Susceptibility Testing Market Dynamics
- Clinical laboratories are increasingly adopting automated and rapid testing technologies to improve turnaround times and clinical outcomes.
- Regulatory mandates for antimicrobial stewardship programs continue to strengthen market demand across hospital systems, diagnostic centers, and reference laboratories. Key growth opportunities exist in point-of-care testing expansion, integration with electronic health records, and adoption of next-generation sequencing-based susceptibility methods.
- The US market will benefit from ongoing healthcare digitalization, rising infection rates, and increased funding for diagnostic infrastructure.
- Strategic partnerships between laboratory service providers and technology vendors are expected to accelerate innovation and market penetration across diverse healthcare settings..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The US antimicrobial susceptibility testing market is valued at $1,485.8 million in 2024 and will reach $1,884.6 million by 2029.
- The US market is growing at a 4.9% CAGR, driven by rising antibiotic resistance and increased diagnostic demand in US clinical laboratories.
- US healthcare facilities are rapidly adopting automated and rapid testing platforms to improve infection control and patient outcomes.
- Antimicrobial stewardship programs and regulatory initiatives are key growth drivers in the US market through 2029.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
US Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- Diagnostic Laboratory Operators : US clinical and reference laboratories need market data to evaluate susceptibility testing technology investments, benchmark operational performance against market trends, and plan capacity expansion aligned with growing diagnostic demand.
- Medical Device & IVD Manufacturers : Companies developing antimicrobial susceptibility testing platforms require US market insights to guide product development roadmaps, identify unmet clinical needs, and strategically position solutions within the competitive American market.
- Hospital & Healthcare System Administrators : US healthcare facility leaders need market intelligence to justify antimicrobial stewardship program investments, evaluate testing platform vendors, and align diagnostic capabilities with regulatory compliance and infection control objectives.
- Infectious Disease & Pathology Specialists : US clinical professionals require market data to understand emerging testing methodologies, evaluate new diagnostic tools, and stay informed on industry standards and best practices in antimicrobial susceptibility assessment.
- Healthcare Investors & Consultants : Investment firms and management consultants need US market analysis to identify growth opportunities, evaluate portfolio companies in the diagnostic sector, and support M&A due diligence in the antimicrobial testing space.
Reasons to Buy this Report
- Quantified Market Sizing : Access precise US market valuation ($1,485.8M in 2024) and 5-year forecast data to support capital allocation decisions, competitive positioning, and revenue projections for antimicrobial susceptibility testing solutions.
- Regulatory & Compliance Insights : Understand US-specific regulatory requirements, CDC guidelines, and CMS mandates driving susceptibility testing adoption, enabling compliant product development and market entry strategies tailored to American healthcare standards.
- Growth Driver Analysis : Identify key US market drivers including antibiotic resistance trends, clinical laboratory modernization initiatives, and antimicrobial stewardship program expansion to prioritize R&D investments and commercial strategies.
- Competitive Landscape Intelligence : Benchmark against US market dynamics, identify emerging opportunities in automated testing platforms and rapid diagnostics, and assess competitive positioning within the American healthcare diagnostic ecosystem.
- Strategic Market Planning : Leverage US-focused market intelligence to develop targeted go-to-market strategies, identify high-potential customer segments, and optimize resource allocation for maximum ROI in the American antimicrobial testing market.
Frequently asked questions
What is the current size of the US antimicrobial susceptibility testing market?
The US antimicrobial susceptibility testing market was valued at $1,485.8 million in 2024.
What is the projected market size for the US by 2029?
The US antimicrobial susceptibility testing market is projected to reach $1,884.6 million by 2029.
What is the growth rate of the US antimicrobial susceptibility testing market?
The US market is expanding at a compound annual growth rate of 4.9% from 2024 to 2029.
What are the primary drivers of growth in the US market?
Key drivers include rising antibiotic resistance, increased diagnostic demand in US clinical laboratories, regulatory emphasis on infection control, and adoption of automated testing platforms.
Which technologies are gaining adoption in the US market?
US healthcare facilities are increasingly adopting automated and rapid testing platforms, as well as next-generation sequencing and molecular diagnostic technologies for antimicrobial susceptibility testing.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
